Arsenic Trioxide as a Vascular Disrupting Agent: Synergistic Effect with Irinotecan on Tumor Growth Delay in a CT26 Allograft Model.

Abstract:

:The mechanism of action of arsenic trioxide (ATO) has been shown to be complex, influencing numerous signal transduction pathways and resulting in a vast range of cellular effects. Among these mechanisms of action, ATO has been shown to cause acute vascular shutdown and massive tumor necrosis in a murine solid tumor model like vascular disrupting agent (VDA). However, relatively little is understood about this VDA-like property and its potential utility in developing clinical regimens. We focused on this VDA-like action of ATO. On the basis of the endothelial cell cytotoxicity assay and tubulin polymerization assay, we observed that higher concentrations and longer treatment with ATO reduced the level of α- and β-tubulin and inhibited the polymerization of tubulin. The antitumor action and quantitative tumor perfusion studies were carried out with locally advanced murine CT26 colon carcinoma grown in female BALB/c mice. A single injection of ATO intraperitoneally displayed central necrosis of the tumor tissue by 24 hours. T1-weighted dynamic contrast-enhanced magnetic resonance image revealed a significant decrease in tumor enhancement in the ATO-treated group. Similar to other VDAs, ATO treatment alone did not delay the progression of tumor growth; however, ATO treatment after injection of other cytotoxic agent (irinotecan) showed significant additive antitumor effect compared to control and irinotecan alone therapy. In summary, our data demonstrated that ATO acts as a VDA by means of microtubule depolymerization. It exhibits significant vascular shutdown activity in CT26 allograft model and enhances antitumor activity when used in combination with another cytotoxic chemotherapeutic agent.

journal_name

Transl Oncol

journal_title

Translational oncology

authors

Lee JC,Lee HY,Moon CH,Lee SJ,Lee WH,Cha HJ,Park S,Lee YH,Park HJ,Song HT,Min YJ

doi

10.1593/tlo.12322

subject

Has Abstract

pub_date

2013-02-01 00:00:00

pages

83-91

issue

1

issn

1936-5233

journal_volume

6

pub_type

杂志文章
  • A Validated Prognostic Biomarker Score for Adult Patients with Nonmetastatic Soft Tissue Sarcomas of the Trunk and Extremities.

    abstract:BACKGROUND:The prognostic value of serum biomarkers in soft tissue sarcoma (STS) is limited, and its clinical applicability is compromised by a common inability to adjust for important confounders. The aim of this study was to determine the prognostic value of pretreatment biomarkers on disease-specific survival (DSS) ...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2017.09.002

    authors: Maretty-Kongstad K,Aggerholm-Pedersen N,Keller J,Safwat A

    更新日期:2017-12-01 00:00:00

  • Markers of Mitochondrial Metabolism in Tumor Hypoxia, Systemic Inflammation, and Adverse Outcome of Rectal Cancer.

    abstract::Tumor hypoxia contributes to therapy resistance and metastatic progression of locally advanced rectal cancer (LARC). We postulated that the tumor mitochondrial metabolism, manifested by reactive oxygen species (ROS) and mitochondrial DNA (mtDNA) damage, reflects how hypoxic conditions connect to cancer-induced systemi...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2018.09.010

    authors: Bousquet PA,Meltzer S,Sønstevold L,Esbensen Y,Dueland S,Flatmark K,Sitter B,Bathen TF,Seierstad T,Redalen KR,Eide L,Ree AH

    更新日期:2019-01-01 00:00:00

  • Cell Population Data-Driven Acute Promyelocytic Leukemia Flagging Through Artificial Neural Network Predictive Modeling.

    abstract::A targeted and timely offered treatment can be a benefitting tool for patients with acute promyelocytic leukemia (APML). Current round of study made use of potential morphological and immature fraction-related parameters (cell population data) generated during complete blood cell count (CBC), through artificial neural...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2019.09.009

    authors: Haider RZ,Ujjan IU,Shamsi TS

    更新日期:2020-01-01 00:00:00

  • Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool.

    abstract::Peritoneal carcinomatosis (PC) of colorectal origin is associated with a poor prognosis. However, cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy is available for a selected group of PC patients, which significantly increases overall survival rates up to 30%. As a consequence, there is su...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1593/tlo.10220

    authors: van Oosten M,Crane LM,Bart J,van Leeuwen FW,van Dam GM

    更新日期:2011-04-01 00:00:00

  • Spatiotemporal Optoacoustic Mapping of Tumor Hemodynamics in a Clinically Relevant Orthotopic Rabbit Model of Head and Neck Cancer.

    abstract::The purpose of this study was to investigate the usefulness of photoacoustic imaging (PAI) for spatiotemporal mapping of tumor hemodynamics in a rabbit model of head and neck carcinoma. Shope cottontail rabbit papilloma virus associated VX2 carcinomas were established in adult male New Zealand White rabbits (n = 9) by...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2017.08.004

    authors: Rich LJ,Sexton S,Curtin L,Seshadri M

    更新日期:2017-10-01 00:00:00

  • Biomarker Discovery in Human Prostate Cancer: an Update in Metabolomics Studies.

    abstract::Prostate cancer (PCa) is the most frequently diagnosed cancer and the second leading cause of cancer death among men in Western countries. Current screening techniques are based on the measurement of serum prostate specific antigen (PSA) levels and digital rectal examination. A decisive diagnosis of PCa is based on pr...

    journal_title:Translational oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.tranon.2016.05.004

    authors: Lima AR,Bastos Mde L,Carvalho M,Guedes de Pinho P

    更新日期:2016-08-01 00:00:00

  • Increased Expression of CAP2 Indicates Poor Prognosis in Hepatocellular Carcinoma.

    abstract::CAP2 has been suggested as a potential diagnostic biomarker for early hepatocellular carcinoma (HCC). However, its prognostic significance in HCC remains unclear. Here, we show that CAP2 expression is much higher in HCC tissues than that in paracarcinoma tissues, at both mRNA and protein levels. Data of immunohistoche...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2015.08.003

    authors: Fu J,Li M,Wu DC,Liu LL,Chen SL,Yun JP

    更新日期:2015-10-01 00:00:00

  • Hydrogen Sulfide Demonstrates Promising Antitumor Efficacy in Gastric Carcinoma by Targeting MGAT5.

    abstract::Mannosyl (alpha-1,6-)-Glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase (MGAT5) is exclusively expressed in gastric carcinoma, and plays an essential role in cancer progression, but no targeted drug is available so far. The potential anti-cancer effect of Hydrogen Sulfide (H2S), has not been widely recognized. It...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2018.04.008

    authors: Wang R,Fan Q,Zhang J,Zhang X,Kang Y,Wang Z

    更新日期:2018-08-01 00:00:00

  • EV20, a Novel Anti-ErbB-3 Humanized Antibody, Promotes ErbB-3 Down-Regulation and Inhibits Tumor Growth In Vivo.

    abstract::ErbB-3 (HER-3) receptor is involved in tumor progression and resistance to therapy. Development of specific inhibitors impairing the activity of ErbB-3 is an attractive tool for cancer therapeutics. MP-RM-1, a murine monoclonal antibody targeting human ErbB-3, has shown anticancer activity in preclinical models. With ...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1593/tlo.13475

    authors: Sala G,Rapposelli IG,Ghasemi R,Piccolo E,Traini S,Capone E,Rossi C,Pelliccia A,Di Risio A,D'Egidio M,Tinari N,Muraro R,Iacobelli S,Consorzio Interuniversitario Nazionale per la Bio-Oncologia (CINBO).

    更新日期:2013-12-01 00:00:00

  • Ibrutinib is not an effective drug in primografts of TCF3-PBX1.

    abstract:AIM:The Bruton's tyrosine kinase (BTK) inhibitor Ibrutinib (PCI-32765) is effective in patients with multiple myeloma, non-Hodgkin lymphoma and chronic lymphoblastic leukemia. We previously showed that primary cells of children with TCF3-PBX1 positive B-cell precursor acute lymphoblastic leukemia (BCP-ALL) express BTK ...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2020.100817

    authors: van de Ven C,Boeree A,Stalpers F,Zwaan CM,Den Boer ML

    更新日期:2020-10-01 00:00:00

  • Acquired Uniparental Disomy Regions Are Associated with Disease Outcome in Patients with Oral Cavity and Oropharynx But Not Larynx Cancers.

    abstract::Acquired uniparental disomy (aUPD) regions pinpoint homozygousity and monoallelic expressed genes. We analyzed The Cancer Genome Atlas single-nucleotide polymorphism arrays and expression data from oral cavity, oropharynx, and larynx cancers to identify frequency of aUPD in each tumor type and association of aUPD regi...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2020.100763

    authors: Tuna M,I Amos C,B Mills G

    更新日期:2020-05-01 00:00:00

  • Magnetic resonance assessment of response to therapy: tumor change measurement, truth data and error sources.

    abstract::This article describes methods and issues that are specific to the assessment of change in tumor characteristics as measured using quantitative magnetic resonance (MR) techniques and how this relates to the establishment of quantitative MR imaging (MRI) biomarkers of patient response to therapy. The initial focus is o...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1593/tlo.09241

    authors: Jackson EF,Barboriak DP,Bidaut LM,Meyer CR

    更新日期:2009-12-01 00:00:00

  • Genetically Modified DR5-Specific TRAIL Variant DR5-B Revealed Dual Antitumor and Protumoral Effect in Colon Cancer Xenografts and an Improved Pharmacokinetic Profile.

    abstract::Despite the weak clinical efficacy of TRAIL death receptor agonists, a search is under way for new agents that more efficiently activate apoptotic signaling. We previously created a TRAIL DR5-selective variant DR5-B without affinity for the DR4, DcR1, DcR2, and OPG receptors and increased proapoptotic activity in tumo...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2020.100762

    authors: Yagolovich AV,Artykov AA,Karmakova TA,Vorontsova MS,Pankratov AA,Andreev-Andrievsky AA,Dolgikh DA,Kirpichnikov MP,Gasparian ME

    更新日期:2020-04-01 00:00:00

  • A Global Risk Score (GRS) to Simultaneously Predict Early and Late Tumor Recurrence Risk after Resection of Hepatocellular Carcinoma.

    abstract:OBJECTIVES:Recurrence of hepatocellular carcinoma can arise from the primary tumor ("early recurrence") or de novo from tumor formation in a cirrhotic environment ("late recurrence"). We aimed to develop one simple gene expression score applicable in both the tumor and the surrounding liver that can predict the recurre...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2016.02.003

    authors: Dekervel J,Popovic D,van Malenstein H,Windmolders P,Heylen L,Libbrecht L,Bulle A,De Moor B,Van Cutsem E,Nevens F,Verslype C,van Pelt J

    更新日期:2016-04-01 00:00:00

  • Can Imaging Parameters Provide Information Regarding Histopathology in Head and Neck Squamous Cell Carcinoma? A Meta-Analysis.

    abstract:OBJECT:Our purpose was to provide data regarding relationships between different imaging and histopathological parameters in HNSCC. METHODS:MEDLINE library was screened for associations between different imaging parameters and histopathological features in HNSCC up to December 2017. Only papers containing correlation ...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2018.02.004

    authors: Surov A,Meyer HJ,Wienke A

    更新日期:2018-04-01 00:00:00

  • Therapeutic relevance of molecular screening program in patients with metastatic sarcoma: Analysis from the ProfiLER 01 trial.

    abstract:BACKGROUND:Advanced sarcoma is a group of heterogeneous disease with poor prognosis and poor efficacy of medical treatment. They represent a promising group of tumors to assess molecular-based therapy (MBT) strategy. PATIENTS AND METHODS:Genomic profiles of patients with advanced sarcoma included in the ProfiLER progr...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2020.100870

    authors: Arnaud-Coffin P,Brahmi M,Vanacker H,Eberst L,Tredan O,Attignon V,Pissaloux D,Sohier E,Cassier P,Garin G,Pérol D,Blay JY,Dufresne A

    更新日期:2020-12-01 00:00:00

  • Colorectal Cancer with Residual Polyp of Origin: A Model of Malignant Transformation.

    abstract::The majority of colorectal cancers (CRCs) arise from adenomatous polyps. In this study, we sought to present the underrecognized CRC with the residual polyp of origin (CRC RPO+) as an entity to be utilized as a model to study colorectal carcinogenesis. We identified all subjects with biopsy-proven CRC RPO+ that were e...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2016.06.002

    authors: Druliner BR,Rashtak S,Ruan X,Bae T,Vasmatzis N,O'Brien D,Johnson R,Felmlee-Devine D,Washechek-Aletto J,Basu N,Liu H,Smyrk T,Abyzov A,Boardman LA

    更新日期:2016-08-01 00:00:00

  • Suitability of surgical tumor tissues, biopsy, or cytology samples for epidermal growth factor receptor mutation testing in non-small cell lung carcinoma based on chinese population.

    abstract:BACKGROUND:Epidermal growth factor receptor (EGFR) mutation status is crucial in treatment selection for non-small cell lung cancer (NSCLC) patients; however, the detection materials' availability remains challenging in clinical practice. In this study, we collected surgical resection tissues, lymph node biopsy, and cy...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2014.10.008

    authors: Han X,Zhang Z,Wu D,Shen Y,Wang S,Wang L,Liu Y,Yang S,Hu X,Feng Y,Sun Y,Shi Y

    更新日期:2014-12-01 00:00:00

  • Long Noncoding RNAs AC009014.3 and Newly Discovered XPLAID Differentiate Aggressive and Indolent Prostate Cancers.

    abstract:INTRODUCTION:The molecular mechanisms underlying aggressive versus indolent disease are not fully understood. Recent research has implicated a class of molecules known as long noncoding RNAs (lncRNAs) in tumorigenesis and progression of cancer. Our objective was to discover lncRNAs that differentiate aggressive and ind...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2018.04.002

    authors: Cesnik AJ,Yang B,Truong A,Etheridge T,Spiniello M,Steinbrink MI,Shortreed MR,Frey BL,Jarrard DF,Smith LM

    更新日期:2018-06-01 00:00:00

  • Differential Expression of Circular RNAs in Glioblastoma Multiforme and Its Correlation with Prognosis.

    abstract:OBJECTIVE:The present study aimed to explore the expression profiles of circular RNAs (circRNAs) in glioblastoma multiforme (GBM) in an attempt to identify potential core genes in the pathogenesis of this tumor. METHODS:Differentially expressed circRNAs were screened between tumor tissues from five GBM patients and fi...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2016.12.006

    authors: Zhu J,Ye J,Zhang L,Xia L,Hu H,Jiang H,Wan Z,Sheng F,Ma Y,Li W,Qian J,Luo C

    更新日期:2017-04-01 00:00:00

  • Smoking-Induced SLPI Expression Hinders HPV Infections Also in Squamous Cell Carcinomas of the Vulva.

    abstract::In HNSCC, protein- and mRNA-expression of the antileukoproteinase SLPI are significantly inverse correlated with HPV-infection suggesting that elevated expression of SLPI protects against HPV-infections. Moreover, SLPI-expression is up-regulated in HNSCC-patients reporting a smoking habit. Here, we investigate the des...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2018.09.004

    authors: Quabius ES,Loehr J,Haaser D,Günther V,Maass N,Röcken C,Mathiak M,Alkatout I,Hoffmann M

    更新日期:2019-01-01 00:00:00

  • Heterogeneous Drug Efficacy of an Antibody-Drug Conjugate Visualized Using Simultaneous Imaging of Its Delivery and Intracellular Damage in Living Tumor Tissues.

    abstract::Anticancer drug efficacy varies because the delivery of drugs within tumors and tumor responses are heterogeneous; however, these features are often more homogenous in vitro. This difference makes it difficult to accurately determine drug efficacy. Therefore, it is important to use living tumor tissues in preclinical ...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2020.100764

    authors: Gonda K,Negishi H,Takano-Kasuya M,Kitamura N,Furusawa N,Nakano Y,Hamada Y,Tokunaga M,Higuchi H,Tada H,Ishida T

    更新日期:2020-06-01 00:00:00

  • Predicting Treatment Response of Breast Cancer to Neoadjuvant Chemotherapy Using Ultrasound-Guided Diffuse Optical Tomography.

    abstract:PURPOSE:To prospectively investigate ultrasound-guided diffuse optical tomography (US-guided DOT) in predicting breast cancer response to neoadjuvant chemotherapy (NAC). MATERIALS AND METHODS:Eighty-eight breast cancer patients, with a total of 93 lesions, were included in our study. Pre- and post-last chemotherapy, s...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2017.10.011

    authors: Zhi W,Liu G,Chang C,Miao A,Zhu X,Xie L,Zhou J

    更新日期:2018-02-01 00:00:00

  • Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer.

    abstract::BRAFV600-mutated colorectal cancer (CRC) accounts for 8% to 12% of all CRC diagnoses. These tumors are often associated with specific patient features, including right-sided primary tumor location, peritoneal and non-regional lymph node involvement, and poor prognosis. In approximately 30% of cases, a simultaneous mis...

    journal_title:Translational oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.tranon.2020.100795

    authors: Roviello G,D'Angelo A,Petrioli R,Roviello F,Cianchi F,Nobili S,Mini E,Lavacchi D

    更新日期:2020-09-01 00:00:00

  • Collaboration Between RSK-EphA2 and Gas6-Axl RTK Signaling in Arginine Starvation Response That Confers Resistance to EGFR Inhibitors.

    abstract::Many human malignancies require extracellular arginine (Arg) for survival because the key enzyme for de novo Arg biosynthesis, argininosuccinate synthetase 1 (ASS1), is silenced. Recombinant arginine deiminase (ADI-PEG20), which digests extracellular Arg, has been in clinical trials for treating ASS1-negative tumors. ...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2019.12.003

    authors: Kuo MT,Long Y,Tsai WB,Li YY,Chen HHW,Feun LG,Savaraj N

    更新日期:2020-02-01 00:00:00

  • PLK1, A Potential Target for Cancer Therapy.

    abstract::Polo-like kinase 1 (PLK1) plays an important role in the initiation, maintenance, and completion of mitosis. Dysfunction of PLK1 may promote cancerous transformation and drive its progression. PLK1 overexpression has been found in a variety of human cancers and was associated with poor prognoses in cancers. Many studi...

    journal_title:Translational oncology

    pub_type: 杂志文章,评审

    doi:10.1016/j.tranon.2016.10.003

    authors: Liu Z,Sun Q,Wang X

    更新日期:2017-02-01 00:00:00

  • Decreased skp2 expression is necessary but not sufficient for therapy-induced senescence in prostate cancer.

    abstract::Therapy-induced senescence (TIS), a cytostatic stress response in cancer cells, is induced inefficiently by current anticancer agents and radiation. The mechanisms that mediate TIS in cancer cells are not well defined. Herein, we characterize a robust senescence response both in vitro and in vivo to the quinone diaziq...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1593/tlo.12181

    authors: Ewald JA,Jarrard DF

    更新日期:2012-08-01 00:00:00

  • Relative expression of KLK5 to LEKTI is associated with aggressiveness of oral squamous cell carcinoma.

    abstract:BACKGROUND:Oral squamous cell carcinoma (OSCC) remains a challenging cancer to treat despite all the advances of the last 50 years. Kallikrein 5 (KLK5) is among the serine proteases implicated in OSCC development. However, whether the activity of KLK5 promotes carcinogenesis is still controversial. Moreover, knowledge ...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2020.100970

    authors: Alves MG,Kodama MH,da Silva EZM,Gomes BBM,da Silva RAA,Vieira GV,Alves VM,da Fonseca CK,Santana AC,Cecílio NT,Costa MSA,Jamur MC,Oliver C,Cunha TM,Bugge TH,Braz-Silva PH,Colli LM,Sales KU

    更新日期:2021-01-01 00:00:00

  • Circulating Exosomal miR-17-5p and miR-92a-3p Predict Pathologic Stage and Grade of Colorectal Cancer.

    abstract::Exosomes are extracellular membrane vesicles of 50- to 130-nm diameter secreted by most tumor cells. Exosomes can mediate the intercellular transfer of proteins and RNAs, including microRNAs (miRNAs), and promote both tumorigenesis and premetastatic niche formation. In this study, we performed exosomal RNA sequencing ...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1016/j.tranon.2017.12.012

    authors: Fu F,Jiang W,Zhou L,Chen Z

    更新日期:2018-04-01 00:00:00

  • Oxidative DNA damage in the prostate may predispose men to a higher risk of prostate cancer.

    abstract::DNA damage has been associated with prostate cancer risk. Men who were referred for initial prostate biopsy for elevated prostate-specific antigen or abnormal digital rectal examination are often found with no cancer but have a higher risk of developing prostate cancer than the general population of men in their lifet...

    journal_title:Translational oncology

    pub_type: 杂志文章

    doi:10.1593/tlo.08217

    authors: Wu JD,Lin DW,Page ST,Lundgren AD,True LD,Plymate SR

    更新日期:2009-03-01 00:00:00